Low expression of RECK indicates a shorter survival for patients with invasive breast cancer

Matrix metalloproteinases and their clinical relevance in urinary bladder cancer

(2011) Tibor Szarvas et al.   Nature Reviews Urology

Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting

(2010) Chrisostomi Gialeli et al.   FEBS Journal

Matrix metalloproteinase-2 and matrix metalloproteinase-9 codistribute with transcription factors RUNX1/AML1 and ETV5/ERM at the invasive front of endometrial and ovarian carcinoma☆

(2010) Jesús Planagumà et al.   HUMAN PATHOLOGY

Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential

(2009) Rita CS Figueira et al.   BMC CANCER

RECK Negatively Regulates Matrix Metalloproteinase-9 Transcription

(2009) Satoshi Takagi et al.   CANCER RESEARCH

MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization

(2009) Yaron Vagima et al.   JOURNAL OF CLINICAL INVESTIGATION